Schlafen 11 Is a Novel Target for Mucosal Regeneration in Ulcerative Colitis
Open Access
- 17 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 15 (9), 1558-1572
- https://doi.org/10.1093/ecco-jcc/jjab032
Abstract
Ulcerative colitis [UC] is a chronic inflammatory disease of the colon with an intractable course. Although the goal of UC therapy is to achieve mucosal healing, the pathogenesis of mucosal injury caused by chronic inflammation remains unknown. We therefore aim to elucidate molecular mechanisms of mucosal injury by establishing in vitro and in vivo humanised UC-mimicking models. An in vitro model using human colon organoids was established by 60 weeks of inflammatory stimulation. The key gene for mucosal injury caused by long-term inflammation was identified by microarray analysis. An in vivo model was established by xenotransplantation of organoids into mouse colonic mucosa. An in vitro model demonstrated that long-term inflammation induced irrecoverable changes in organoids: inflammatory response and apoptosis with oxidative stress and suppression of cell viability. This model also mimicked organoids derived from patients with UC at the gene expression and phenotype levels. Microarray analysis revealed Schlafen11 [SLFN11] was irreversibly induced by long-term inflammation. Consistently, SLFN11 was highly expressed in UC mucosa but absent in normal mucosa. The knockdown of SLFN11 [SLFN11-KD] suppressed apoptosis of intestinal epithelial cells [IECs] induced by inflammation. Moreover, SLFN11-KD improved the take rates of xenotransplantation and induced the regenerative changes of crypts observed in patients with UC in remission. In vitro and in vivo UC-mimicking models were uniquely established using human colonic organoids. They revealed that SLFN11 is significant for mucosal injury in UC, and demonstrated its potential as a novel target for mucosal regeneration.Funding Information
- Japanese Ministry of Education, Culture, Sports, Science and Technology (17H06654, 17K15930, 17K19513, 18H02791, 18K19535, 19K17425, 19H01050)
- Japan Agency for Medical Research and Development (18bm03041h0006, 19bm0304001h0007)
- Naoki Tsuchida Research Grant
This publication has 29 references indexed in Scilit:
- Reduced Human α-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn’s DiseaseInflammatory Bowel Diseases, 2016
- Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel diseaseThe Esophagus, 2015
- Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoidsNature Medicine, 2015
- Fluorescent labelling of intestinal epithelial cells reveals independent long-lived intestinal stem cells in a cryptBiochemical and Biophysical Research Communications, 2014
- Mucosal healing in inflammatory bowel diseases: a systematic reviewGut, 2012
- Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cellNature Medicine, 2012
- Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitisInflammatory Bowel Diseases, 2011
- Role of Interferon α (IFNα)-inducible Schlafen-5 in Regulation of Anchorage-independent Growth and Invasion of Malignant Melanoma CellsJournal of Biological Chemistry, 2010
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheNature, 2009
- Requirement of Notch activation during regeneration of the intestinal epitheliaAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009